Medical News / Reported from ERS 2020: Michael Wechsler, MD - Asthma Patients During COVID-19

When the coronavirus disease 2019 (COVID-19) pandemic began it was conventional wisdom that asthma patients might fare worse than other individuals because the viral infection tends to attack the lungs more than other organ systems. However, 6 months of data shows that asthma patients do not have significantly worse COVID-19 outcomes than the general population. In an interview with HCPLive®, Michael E. Wechsler, MD, MMSc, Director of the National Jewish Cohen Family Asthma Institute, said 1 of the main reasons for this trend could be that asthma patients tend to adhere to their medications. Source: MDMag To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

According to new phase 3 data presented at the American Academy of Ophthalmology 2021 Meeting, brolucizumab ... read more
In an interview with HCPLive, Veeral Sheth, MD, Director of Clinical Trials, University Retina, discussed the ... read more
Access to US ophthalmology clinical trial sites may differ by region, according to new study findings ... read more
Although there are questions on the rationale behind step therapy, particularly for neovascular (wet) age-related macular ... read more